The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era
Daniel E. Lieberman, Daniel H. Aslan, Steven B. Heymsfield
原始摘要（英文原文）· Original abstract
This Perspective describes the challenges of prescribing exercise for weight loss, with and without the use of glucagon-like peptide 1 (GLP-1) receptor agonists, and discusses strategies clinicians can use to improve adherence to exercise recommendations.